Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders

This study has been completed.
Lundbeck Foundation
Aarhus University Hospital
Vejle Hospital
Sydvestjysk Hospital
Steno Diabetes Center
University of Copenhagen
Information provided by (Responsible Party):
Julie Støy, University of Aarhus Identifier:
First received: April 3, 2012
Last updated: December 1, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):